133 results
Page 4 of 7
424B5
tyr woqlgj
19 Sep 19
Prospectus supplement for primary offering
5:18pm
424B3
z3qoxvgd xv
16 Sep 19
Prospectus supplement
6:14am
8-K
EX-10.1
1q7y619t dme
30 Aug 19
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
71foppok1n xdpj
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
oce54ta6087
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
uyzyz6by9 e4fa
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-2.1
wwwqqmy4h6 vb16ge
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-2.3
kj7ry5rp6dt3v3sn
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-99.1
irj u30tw
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-99.1
rh8exq2wdlt
25 Jan 19
AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results
7:46am
8-K
EX-99.1
f3t3 28t3gfns7vli9qz
2 Nov 18
AbbVie Reports Third-Quarter 2018 Financial Results
7:50am
424B5
e310c
13 Sep 18
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
c535p71pw4u46 z6z9is
18 May 18
Entry into a Material Definitive Agreement
5:05pm